To further investigate whether the presence of exon 7 of LRRFIP2 variant 3 is indeed important for dramatic changes in metastatic potential in gastric cancer cells, we deleted exon 7 of endogenous LRRFIP2 variant 3 using the CRISPR/Cas9 system. This evidence concerns the gene LRRFIP2 and gastric cancer.